Overview
PEPG market data
Price History
PEPG price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.12 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.98 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.01 – $7.80 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $206.4M · P/B 3.04.
Company News
PepGen Q2 EPS $(0.26) Beats $(0.29) EstimateBenzinga · Aug 6, 2026, 12:04 PM
8-K filing — PepGen Inc. (PEPG)SEC EDGAR · Aug 6, 2026, 11:40 AM
PepGen Receives Recommendation To Advance its Phase 2 FREEDOM2-DM1 Study Of PGN-EDODM1 In Participants With Myotonic Dystrophy Type 1 Into The Highest Dose CohortBenzinga · Aug 6, 2026, 11:37 AM
Craig-Hallum Initiates Coverage On PepGen with Buy Rating, Announces Price Target of $11Benzinga · Jun 16, 2026, 2:40 PM
PepGen To Highlight Data From PGN-EDODM1 Program In Poster And Late-Breaking Oral Presentation At IDMC-15Benzinga · May 21, 2026, 11:10 AM
PepGen Files For $400M Shelf Registration And $100M At-The-Market Stock OfferingBenzinga · May 19, 2026, 4:10 PM